Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
in vitro gene mutation study in bacteria
Type of information:
experimental study
Adequacy of study:
key study
Study period:
2016-11-08 to 2016-12-22
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2016
Report date:
2016

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 471 (Bacterial Reverse Mutation Assay)
Version / remarks:
21st July 1997
Deviations:
no
GLP compliance:
yes (incl. QA statement)
Type of assay:
bacterial reverse mutation assay

Test material

Constituent 1
Chemical structure
Reference substance name:
Butyl ethyl ether
EC Number:
211-055-7
EC Name:
Butyl ethyl ether
Cas Number:
628-81-9
Molecular formula:
C6H14O
IUPAC Name:
1-ethoxybutane
Test material form:
liquid
Details on test material:
- Source and batch No.of test material: 60930023
- Expiration date of the batch: 09/2021
- Purity: 98.4%
- Physical State: liquid
- Density: 0.75 g/cm³
- Colour: colourless
- Storage condition of test material: Keep container tightly closed. Store in a dry and cool area
Specific details on test material used for the study:
TREATMENT OF TEST MATERIAL PRIOR TO TESTING
- Treatment of test material prior to testing: The test item was dissolved in DMSO and diluted prior to treatment. The solvent was compatible
with the survival of the bacteria and the S9 activity.

Method

Target gene:
Histidine locus
Species / strain
Species / strain / cell type:
S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and TA 102
Details on mammalian cell type (if applicable):
Source of cells: MOLTOX, INC., NC 28607, USA (TA 98, 1535 and 102), Xenometrix AG, Switzerland (TA 100 and 1537).
Nutrient medium: 8 g Nutrient Broth and 5 g NaCl per litre
Selective Agar: 2% Vogel-Bonner-Glucose-Minimal Agar
Overlay Agar: 7.0 g Agar Agar, 6.0 g NaCl, 10.5 mg L-hisitidne x HCl x H2O, 12.2 mg Biotin per litre
Metabolic activation:
with and without
Metabolic activation system:
Mammalian Microsomal Fraction S9 Mix
Test concentrations with justification for top dose:
The test item concentrations to be applied in the main experiments were chosen according to the results of the pre-experiment (Conditions: see "Any other information on materials and methods"; Results: see "Any other information on results" Table 2). 5.0 μL/plate was selected as the maximum concentration. The concentration range covered two logarithmic decades. Two independent experiments were performed with the following concentrations:
0.0316, 0.100, 0.316, 1.0, 2.5 and 5.0 μL/plate
Vehicle / solvent:
- Vehicle(s)/solvent(s) used: DMSO
- Justification for choice of solvent/vehicle: The solvent was compatible with the survival of the bacteria and the S9 activity.
Controlsopen allclose all
Untreated negative controls:
yes
Remarks:
Aqua dest.
Negative solvent / vehicle controls:
yes
Remarks:
DMSO
True negative controls:
no
Positive controls:
yes
Positive control substance:
sodium azide
Untreated negative controls:
yes
Remarks:
Aqua dest.
Negative solvent / vehicle controls:
yes
Remarks:
DMSO
True negative controls:
no
Positive controls:
yes
Positive control substance:
other: 4-nitro-o-phenylene-diamine (4-NOPD)
Untreated negative controls:
yes
Remarks:
Aqua dest.
Negative solvent / vehicle controls:
yes
Remarks:
DMSO
True negative controls:
no
Positive controls:
yes
Positive control substance:
methylmethanesulfonate
Untreated negative controls:
yes
Remarks:
Aqua dest.
Negative solvent / vehicle controls:
yes
Remarks:
DMSO
True negative controls:
no
Positive controls:
yes
Positive control substance:
other: 2-aminoanthracene
Details on test system and experimental conditions:
METHOD OF APPLICATION: in medium; in agar (plate incorporation (experiment I)); preincubation (experiment II)
- Cell density at seeding (if applicable): approx. 10^9 cells/mL 100µL/plate

EXPERIMENTAL PROCEDURE
- Experiment I:
For the plate incorporation method the following materials were mixed in a test tube and poured over the surface of a minimal agar plate:
100 μL Test solution at each dose level, solvent control, negative control or reference mutagen solution (positive control), 500 μL S9 mix (for testing with metabolic activation) or S9 mix substitution buffer (for testing without metabolic activation), 100 μL Bacteria suspension (cf. Preparation of Bacteria, pre-culture of the strain), 2000 μL Overlay agar.
- Experiment II:
For the pre-incubation method 100 μL of the test item preparation was pre-incubated with the tester strains (100 μL) and sterile buffer or the metabolic activation system (500 μL) for 60 min at 37 °C prior to adding the overlay agar (2000 μL) and pouring onto the surface of a minimal agar plate.

DURATION
- Preincubation period: 60 min at 37 °C
- Exposure duration: 48 h at least

NUMBER OF REPLICATIONS: 3

DETERMINATION OF CYTOTOXICITY
Cytotoxicity can be detected by a clearing or rather diminution of the background lawn (indicated as "N" or "B", respectively in the result tables) or a reduction in the number of revertants down to a mutation factor of approximately ≤ 0.5 in relation to the solvent control.
Evaluation criteria:
The Mutation Factor is calculated by dividing the mean value of the revertant counts by the mean values of the solvent control (the exact and not the rounded values are used for calculation).
A test item is considered as mutagenic if:
- a clear and dose-related increase in the number of revertants occurs and/or
- a biologically relevant positive response for at least one of the dose groups occurs in at least one tester strain with or without metabolic activation.

A biologically relevant increase is described as follows:
- if in tester strains TA 98, TA 100 and TA 102 the number of reversions is at least twice as high
- if in tester strains TA 1535 and TA 1537 the number of reversions is at least three times higher than the reversion rate of the solvent control.

A test item producing neither a dose related increase in the number of revertants nor a reproducible biologically relevant positive response at any of the dose groups is considered to be non-mutagenic in this system.
Statistics:
According to OECD guidelines, the biological relevance of the results is the criterion for the interpretation of results, a statistical evaluation of the results is not regarded as necessary.

Results and discussion

Test resultsopen allclose all
Key result
Species / strain:
S. typhimurium, other: TA 98, TA 100, TA 1535, TA 1537 and TA 102
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
no cytotoxicity
Vehicle controls validity:
valid
Untreated negative controls validity:
valid
Positive controls validity:
valid
Key result
Species / strain:
S. typhimurium, other: TA 98, TA 100, TA 1535, TA 1537 and TA 102
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
cytotoxicity
Remarks:
≥ 2.5 µL/plate without S9 and at 5 µL/plate with S9 in TA 98, TA 100, TA 1535 and TA 1537. At 5 µL/plate without S9 in TA 102
Vehicle controls validity:
valid
Untreated negative controls validity:
valid
Positive controls validity:
valid
Additional information on results:
No precipitation of the test item was observed in any tester strain used in experiment I and II (with and without metabolic activation). No toxic effects of the test item were noted in any of the five tester strains used up to the highest dose group evaluated with and without metabolic activation in experiment I. In experiment II in tester strains TA 98, TA 100, TA 1535 and TA 1537 toxic effects of the test item were noted at concentrations of 2.5 µL/plate and higher (without metabolic activation) and at 5.0 µL/plate with metabolic activation). In tester strain TA 102 toxic effects of the test item were noted at a concentration of 5.0 µL/plate (without metabolic activation). No biologically relevant increases in revertant colony numbers of any of the five tester strains were observed following treatment with butyl ethyl ether at any concentration level, neither in the presence nor absence of metabolic activation in experiment I and II. All criteria of validity were met.
Remarks on result:
other: Experiment I (plate incorporation)

Any other information on results incl. tables

Results of the pre-experiment

Table 2: Results pre-experiment

  Dose (µL/plate) TA 98 TA 100
Mutation Factor [toxicity]*  Mutation Factor [toxicity]*
without S9 with S9 without S9 with S9
Solvent Control (DMSO)   1.0 1.0 1.0 1.0
4-NOPD 10 µg 19.8 - - -
NaN3 10 µg - - 10.3 -
2-AA 2.5 µg - 95.2 - 28.5
Test Item
Butyl ethyl ether
0.00316 1.2 0.8 0.9 0.9
0.0100 1.2 0.9 1.0 0.9
0.0316 1.1 0.8 1.0 0.9
0.100 1.4 1.0 1.1 0.9
0.316 1.2 0.7 1.0 1.0
1.0 0.9 0.8 1.0 1.1
2.5 1.0 0.9 1.0 1.1
5.0 1.2 0.9 1.0 1.1

* [toxicity parameter]: B = Background lawn reduced, N = No background lawn

Applicant's summary and conclusion

Conclusions:
Based on the results of this guideline study (OECD 471), butyl ethyl ether is considered to be non-mutagenic in the bacterial reverse mutation assay.
Executive summary:

In a reverse gene mutation assay in bacteria, strains TA 98, TA 100, TA 1535, TA 1537 and TA 102 of S. typhimurium were exposed to butyl ethyl ether (98.4 % purity) in DMSO at concentrations of 0.00316, 0.0100, 0.0316, 0.100, 0.316, 1.0, 2.5 and 5.0 µL/plate in two individual experiments (plate-incorporation and pre-incubation) each in the presence and absence of mammalian metabolic activation. No cytotoxic effects were observed in experiment I, while in experiment II cytotoxicity was seen in TA 98, TA 100, TA 1535 and TA 1537 at concentrations of 2.5 µL/plate and higher (without metabolic activation) and at the limit concentration (5.0 µL/plate) with metabolic activation. In tester strain TA 102 toxic effects were noted at a concentration of 5.0 µL/plate (without metabolic activation). The positive controls induced the appropriate responses in the corresponding strains. There was no evidence of induced mutant colonies over background in all tester strains in both experiments. Therefore, butyl ethyl ether is considered to be non-mutagenic in this Salmonella typhimurium reverse mutation assay.

This study is classified as acceptable and satisfies the requirement for Test Guideline OECD 471 for in vitro mutagenicity (bacterial reverse gene mutation assay).